Skip to content

NTHI NTHI Debt-to-equity

Debt-to-equity at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
2.2×-0.6×
Pfizer logo
PfizerPFE
0.7×0.0×
Merck & Co. logo
Merck & Co.MRK
1.1×+0.3×
Oric Pharmaceuticals, Inc. logo
Oric Pharmaceuticals, Inc.ORIC
0.0×
Nuvation Bio logo
Nuvation BioNUVB
0.2×+0.2×
Crinetics Pharmaceuticals logo
Crinetics PharmaceuticalsCRNX
0.0×

Other financials

Income statement

See full
Revenue$40.0K-7.0%
Operating income-$7.1M+77.9%
Net income-$8.8M+72.7%
EPS (diluted)-$0.38+78.7%

Balance sheet

See full
Cash & equivalents$138.6K-97.5%
Total debt$666.1K
Total equity-$13.2M-37.5%
Total assets$3.3M-60.6%

Cash flow

See full
Operating cash flow-$7.0M-23.7%
CapEx$125.0K
Free cash flow-$5.2M

Valuation

See full
Market cap$114.62M+51.0%
Enterprise value$115.15M+51.1%
P/S1,432.9×

Profitability

See full
Operating margin-46,870.7%
Net margin-51,613.3%
FCF margin-26,083.2%

Returns & leverage

See full
Return on equity338.1%
Current ratio0.1×-0.3×